A new stem cell technique has been developed by scientists at Memorial Sloan-Kettering Cancer Center that may lead to quicker treatment for cancer and reduce dependence on chemotherapy. Researchers reprogrammed T-cells to fight the patients' cancer. "This means fewer side effects and secondly, because they stay in the body, they are 'living drugs' and once present move around and stop recurrences," said lead researcher Dr. Michel Sadelain.

Related Summaries